VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by Altcarbackon Mar 13, 2017 5:32pm

202 Views

Post# 25973579

RE:RE:VPT-Cost Advantage Their Huge Benefit Against GE etc

Stinkbid, what do you think would be the multiple when and if VPT starts taking oders ? 10 X, 20X ? considering the sector they operate in and the expanding business?

I tell you it would'nt take much expected green ink to send this one much higher....

Not pumping, Dave....:-)

Bullboard Posts

Changing Europe’s dependency on HREE from China